Drawing for LYSIN C

USPTO serial 76241989

LYSIN C

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
BUSH, KAREN K
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LYSIN C?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roy S. Gordet

ROY S GORDET ROY S. GORDET, ATTORNEY AT LAW98 BATTERY ST STE 601SAN FRANCISCO, CA 94111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for use in the treatment of heart disease and heart conditions, diabetes, menstrual disorders, blood pressure problems, cardiovascular problems, lipid metabolism disorders, asthma, arthritis, arthrosis, tinnitus,periodontosis, anemia, cell deficiencies, and cancer; vitamins and minerals for medical purposes; food supplements for non-medical purposes, consisting primarily of vitamins, amino acids and trace elements; dietetic supplements for non-medical use, namely amino acids and trace elements in the nature of dietary supplements; nutritionally fortified beveragesACTIVE—
016printed materials, namely books, pamphlets, magazines, journals, newspapers, and printed teaching and educational materials, in the fields of health care, preventative health care, nutritional supplements, dietary supplements, vitamins and mineral supplementsACTIVE—
033mineral and carbonated water; other non-alcoholic beverages, namely fruit drinks and fruit juices; preparations, namely syrups, powders, and tablets, for making fortified beveragesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 12, 2004ABN1ABANDONMENT - EXPRESS MAILED—
Mar 23, 2004EMRVEMAIL RECEIVED—
Mar 22, 2004GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 21, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 2, 2003CFITCASE FILE IN TICRS—
Jun 19, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 27, 2003GNSLLETTER OF SUSPENSION E-MAILED—
Apr 1, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 2003MAILPAPER RECEIVED—
Oct 2, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2002TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 16, 2002DOCKASSIGNED TO EXAMINER—
Sep 13, 2002PETGPETITION TO REVIVE-GRANTED—
Jul 17, 2002PETRPETITION TO REVIVE-RECEIVED—
Jul 17, 2002PETRPETITION TO REVIVE-RECEIVED—
Jul 17, 2002MAILPAPER RECEIVED—
May 20, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 15, 2001UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Nov 5, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 6, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2001DOCKASSIGNED TO EXAMINER—
Jul 23, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance